Squarepoint Ops LLC - REVANCE THERAPEUTICS INC ownership

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 155 filers reported holding REVANCE THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 1.49 and the average weighting 0.4%.

Quarter-by-quarter ownership
Squarepoint Ops LLC ownership history of REVANCE THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$815,134
-71.6%
32,206
-63.9%
0.00%
-83.3%
Q1 2023$2,874,066
+80.9%
89,229
+3.7%
0.01%
+100.0%
Q4 2022$1,588,686
+214.0%
86,061
+359.0%
0.01%
+100.0%
Q3 2022$506,000
+7.7%
18,751
-44.9%
0.00%0.0%
Q2 2022$470,000
-28.4%
34,004
+1.1%
0.00%0.0%
Q1 2022$656,000
-27.4%
33,647
+10.5%
0.00%0.0%
Q2 2021$903,000
+221.4%
30,463
+202.6%
0.00%
+50.0%
Q1 2021$281,000
-53.3%
10,067
-58.0%
0.00%
-75.0%
Q3 2020$602,000
-57.8%
23,946
-59.0%
0.01%
-65.2%
Q2 2020$1,425,000
+229.1%
58,369
+99.4%
0.02%
+109.1%
Q1 2020$433,000
-38.4%
29,266
-32.5%
0.01%
+175.0%
Q4 2019$703,000
-19.7%
43,340
-35.8%
0.00%
-55.6%
Q2 2019$876,000
+102.3%
67,528
+146.0%
0.01%
+80.0%
Q1 2019$433,000
+69.8%
27,446
+117.0%
0.01%
+66.7%
Q4 2018$255,000
-42.6%
12,647
-29.2%
0.00%
-40.0%
Q3 2018$444,000
-15.9%
17,868
+4.3%
0.01%
-37.5%
Q1 2018$528,000
-54.1%
17,130
-46.8%
0.01%
-60.0%
Q4 2017$1,151,00032,1910.02%
Other shareholders
REVANCE THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Palo Alto Investors LP 4,415,689$86,106,0006.66%
Evolutionary Tree Capital Management, LLC 176,336$3,439,0002.39%
Essex Woodlands Management, Inc. 457,085$8,913,0002.16%
HealthCor Management, L.P. 1,423,425$27,757,0001.85%
RICE HALL JAMES & ASSOCIATES, LLC 1,112,325$21,690,0000.86%
Waypoint Capital Advisors, LLC 53,989$1,016,0000.60%
Antara Capital LP 679,600$13,252,0000.40%
Rhenman & Partners Asset Management AB 198,358$3,868,0000.38%
Walleye Capital LLC 505,701$9,861,0000.26%
Polar Capital Holdings Plc 2,456,497$47,902,0000.22%
View complete list of REVANCE THERAPEUTICS INC shareholders